Friday, July 7, 2023: Life Sciences

On Thursday, the US Food and Drug Administration (FDA) granted traditional full approval to the Alzheimer’s drug Leqembi. The Centers for Medicare and Medicaid Services (CMS) said Thursday that it will now expand coverage of the drug, broadening access for up to an...

Wednesday, July 5, 2023: Providers

Stanford Medicine and the Department of Veterans Affairs (VA) unveiled plans Friday to collaborate on a project that will bring a new National Cancer Institute-designated joint cancer care and research center to the VA Palo Alto campus in California. The two...

Wednesday, July 5, 2023: Payers

A new report from the Urban Institue says that the Centers for Medicare and Medicaid Services’ (CMS) quality bonus program is ineffective in many cases as it overpays Medicare Advantage organizations and needs reform. The bonus program, established by the Affordable...